The completion of series B fundraise of £10.3 million
The appointment of Paul Atherton as Chairman
COMPLETION OF SERIES B FUNDRAISE
Pharmaceutical
Thu, 23/05/2019 - 07:00
Tue, 21/05/2019 - 15:15
Coventry, UK, 21st May 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage developer of innovat
Tue, 21/05/2019 - 07:00
London, UK, 21st May 2019 / Sciad Newswire / The £27m UK Innovation & Science Seed Fund (UKI2S) and In
Thu, 16/05/2019 - 14:00
Edinburgh, UK, 16th May 2019 / Sciad Newswire / Synpromics Ltd, the leader in gene control, and
Thu, 09/05/2019 - 08:00
Sales results drive increased profits
Thu, 09/05/2019 - 07:00
Cell encapsulation for transport of cells and tissues at room temperature
Thu, 25/04/2019 - 07:00
Bournemouth, UK, and Fordingbridge, UK, 25th April 2019 / Sciad Newswire / Solentim, the
Wed, 27/03/2019 - 07:30
A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources
Thu, 21/03/2019 - 10:31
London, UK, 21st March 2019 / Sciad Newswire / Inspired by the success of Pharma Integrates, Life Science Integra
Tue, 12/03/2019 - 07:00
Unique management tool for minimizing costs, drug waste and risk